Novavido

Bologna, Italy Founded: 2021 • Age: 5 yrs
An injectable artificial retina for retinal degeneration is developed.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees 1 Tracked headcount
Investors - Known backers
Products 1 Services tracked
Competitors 3 Brand Intelligence

About Novavido

Novavido is a company based in Bologna (Italy) founded in 2021. The company has 1 employees as of July 01, 2024. Novavido offers products and services including Retinal Device. Novavido operates in a competitive market with competitors including Samsara Vision and Espansione Group, among others.

  • Headquarter Bologna, Italy
  • Employees 1 as on 01 Jul, 2024
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Novavido S.R.L.
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    1

    as on Jul 01, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Novavido

Novavido offers a comprehensive portfolio of products and services, including Retinal Device.

Product name locked
Category locked
Primary

Device replaces damaged photoreceptors for treating eye diseases.

Funding Insights of Novavido

Premium access

Detailed funding history for Novavido

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Novavido

Investments
Premium access

Investment portfolio details for Novavido

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Novavido

Premium access

Detailed financials for Novavido

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Novavido Comparisons

Novavido Primary company
Description
An injectable artificial retina for retinal degeneration is ...
Location
Bologna, Italy
Founded Year
2021
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
1
As of 2024
Premium access

Peer comparison for Novavido

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Novavido

Novavido operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Samsara Vision and Espansione Group, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of a specialty medical device company focusing on the development, manufacturing, and marketing of proprietary implantable ophthalmic devices designed to improve central vision for late-stage age-related macular degeneration (AMD) patients
Locked Locked Locked
Developer of Photobiostimulation for various medical applications
Premium access

Detailed competitors of Novavido

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Novavido

Premium access

Complete news archive for Novavido

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Novavido

Novavido was founded in 2021.

Novavido is headquartered in Bologna, Italy. It is registered at Bologna, Emilia-romagna, Italy.

John Manfredi is the current CEO of Novavido.

As of Jul 01, 2024, the latest employee count at Novavido is 1.

Novavido was founded in 2021 in Bologna, Italy, as a developer of medical devices targeting retinitis pigmentosa and macular degeneration. An aqueous injectable device is offered, in which photoactive polymeric nanoparticles are suspended to substitute for damaged photoreceptors. Vision restoration across the full visual field is enabled through this biotechnology approach, with operations focused on research and device innovation in the ophthalmology sector.

Novavido's top competitors include Samsara Vision and Espansione Group.

Novavido offers Retinal Device.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available